{"id":9052,"date":"2026-10-26T03:07:44","date_gmt":"2026-10-26T00:07:44","guid":{"rendered":"https:\/\/ulubeydental.com\/sistemik-hastaliklar-ve-agiz-sagligi\/"},"modified":"2026-10-26T03:07:44","modified_gmt":"2026-10-26T00:07:44","slug":"sistemik-hastaliklar-ve-agiz-sagligi","status":"publish","type":"post","link":"https:\/\/ulubeydental.com\/tr\/sistemik-hastaliklar-ve-agiz-sagligi\/","title":{"rendered":"Diyabet, Kalp Hastal\u0131\u011f\u0131 ve \u0130la\u00e7lar: A\u011f\u0131z Sa\u011fl\u0131\u011f\u0131n\u0131z\u0131 Nas\u0131l Etkiler?"},"content":{"rendered":"\n<style>\n  .ub-clinical-post {\n    font-family: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, \"Helvetica Neue\", Arial, sans-serif;\n    color: #1e293b;\n    line-height: 1.85;\n    font-size: 17px;\n    max-width: 940px;\n    margin: 0 auto;\n    padding: 10px 0;\n  }\n  .ub-clinical-post p {\n    margin-bottom: 1.6rem;\n    color: #334155;\n  }\n  .ub-clinical-post h2 {\n    color: #0f172a;\n    font-size: 1.8rem;\n    font-weight: 700;\n    margin-top: 3.2rem;\n    margin-bottom: 1.25rem;\n    line-height: 1.3;\n    border-bottom: 2px solid #e2e8f0;\n    padding-bottom: 0.6rem;\n    scroll-margin-top: 80px;\n  }\n  .ub-clinical-post h3 {\n    color: #0369a1;\n    font-size: 1.35rem;\n    font-weight: 600;\n    margin-top: 2.2rem;\n    margin-bottom: 0.9rem;\n    scroll-margin-top: 80px;\n  }\n  \n  \/* BYLINE & EEAT CARD *\/\n  .ub-byline-card {\n    background: #f8fafc;\n    border: 1px solid #cbd5e1;\n    border-left: 5px solid #0284c7;\n    border-radius: 8px;\n    padding: 20px 24px;\n    margin-bottom: 2rem;\n    font-size: 0.93rem;\n  }\n  .ub-badge {\n    display: inline-block;\n    background: #e0f2fe;\n    color: #0284c7;\n    font-weight: 700;\n    font-size: 0.75rem;\n    padding: 3px 12px;\n    border-radius: 9999px;\n    margin-right: 8px;\n    text-transform: uppercase;\n    letter-spacing: 0.05em;\n  }\n  .ub-badge-gold {\n    background: #fef3c7;\n    color: #b45309;\n  }\n\n  \/* FAST-EXTRACTION AI \/ CLINICAL SUMMARY BOX *\/\n  .ub-ai-summary-box {\n    background: #f0fdf4;\n    border: 2px solid #86efac;\n    border-radius: 10px;\n    padding: 24px 26px;\n    margin: 2.2rem 0;\n    box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.05);\n  }\n  .ub-ai-summary-header {\n    display: flex;\n    align-items: center;\n    gap: 10px;\n    font-size: 1.15rem;\n    font-weight: 700;\n    color: #166534;\n    margin-bottom: 12px;\n    text-transform: uppercase;\n    letter-spacing: 0.03em;\n  }\n  .ub-ai-summary-grid {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n    gap: 12px 20px;\n    margin-top: 14px;\n    font-size: 0.92rem;\n    color: #14532d;\n  }\n  .ub-ai-summary-item {\n    background: #ffffff;\n    border: 1px solid #bbf7d0;\n    padding: 10px 14px;\n    border-radius: 6px;\n  }\n  .ub-ai-summary-item strong {\n    color: #0f172a;\n    display: block;\n    margin-bottom: 2px;\n  }\n\n  \/* TABLE OF CONTENTS *\/\n  .ub-toc-box {\n    background: #ffffff;\n    border: 1px solid #e2e8f0;\n    border-radius: 10px;\n    padding: 22px 26px;\n    margin: 2rem 0;\n    box-shadow: 0 2px 4px rgba(0,0,0,0.02);\n  }\n  .ub-toc-title {\n    font-size: 1.1rem;\n    font-weight: 700;\n    color: #0f172a;\n    margin-bottom: 12px;\n    display: flex;\n    align-items: center;\n    gap: 8px;\n  }\n  .ub-toc-list {\n    list-style: none;\n    padding: 0;\n    margin: 0;\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(340px, 1fr));\n    gap: 8px 16px;\n  }\n  .ub-toc-list li a {\n    color: #0284c7;\n    text-decoration: none;\n    font-size: 0.92rem;\n    font-weight: 500;\n    display: inline-flex;\n    align-items: center;\n    gap: 6px;\n  }\n  .ub-toc-list li a:hover {\n    color: #0369a1;\n    text-decoration: underline;\n  }\n\n  \/* MEDIA CONTAINER *\/\n  .ub-media-card {\n    background: #f8fafc;\n    border: 1px solid #e2e8f0;\n    border-radius: 12px;\n    padding: 16px;\n    margin: 2.5rem 0;\n    text-align: center;\n  }\n  .ub-media-img {\n    max-width: 100%;\n    height: auto;\n    border-radius: 8px;\n    box-shadow: 0 4px 6px -1px rgba(0,0,0,0.05);\n  }\n  .ub-media-caption {\n    font-size: 0.88rem;\n    color: #64748b;\n    margin-top: 10px;\n    line-height: 1.5;\n  }\n  .ud-diagram {\n    margin: 2.5rem auto;\n    text-align: center;\n  }\n  .ud-diagram img {\n    display: block;\n    margin: 0 auto;\n    border-radius: 8px;\n    box-shadow: 0 4px 6px -1px rgba(0,0,0,0.05);\n  }\n  .ud-diagram figcaption {\n    font-size: 0.88rem;\n    color: #64748b;\n    margin-top: 10px;\n    line-height: 1.5;\n  }\n\n  \/* BENCHMARK METRIC CARDS *\/\n  .ub-metric-grid {\n    display: grid;\n    grid-template-columns: repeat(auto-fit, minmax(240px, 1fr));\n    gap: 16px;\n    margin: 2.5rem 0;\n  }\n  .ub-metric-card {\n    background: #ffffff;\n    border: 1px solid #e2e8f0;\n    border-top: 4px solid #0284c7;\n    border-radius: 8px;\n    padding: 20px 22px;\n    box-shadow: 0 2px 4px rgba(0,0,0,0.03);\n  }\n  .ub-metric-val {\n    font-size: 2rem;\n    font-weight: 800;\n    color: #0284c7;\n    line-height: 1.1;\n    margin-bottom: 6px;\n  }\n  .ub-metric-label {\n    font-weight: 700;\n    color: #0f172a;\n    font-size: 0.98rem;\n    margin-bottom: 6px;\n  }\n  .ub-metric-desc {\n    font-size: 0.86rem;\n    color: #64748b;\n    line-height: 1.5;\n  }\n\n  \/* CALLOUT BOXES *\/\n  .ub-callout-box {\n    background: #f8fafc;\n    border: 1px solid #e2e8f0;\n    border-left: 4px solid #0284c7;\n    border-radius: 8px;\n    padding: 22px 24px;\n    margin: 2rem 0;\n  }\n  .ub-callout-box.alert {\n    background: #fef2f2;\n    border-color: #fecaca;\n    border-left-color: #dc2626;\n  }\n  .ub-callout-title {\n    font-weight: 700;\n    font-size: 1.1rem;\n    margin-bottom: 0.6rem;\n    display: flex;\n    align-items: center;\n    gap: 8px;\n  }\n  .ub-callout-box .ub-callout-title { color: #0369a1; }\n  .ub-callout-box.alert .ub-callout-title { color: #991b1b; }\n\n  \/* COMPARISON TABLES *\/\n  .ub-table-wrapper {\n    overflow-x: auto;\n    margin: 2.5rem 0;\n    border: 1px solid #e2e8f0;\n    border-radius: 8px;\n  }\n  .ub-table {\n    width: 100%;\n    border-collapse: collapse;\n    font-size: 0.93rem;\n    text-align: left;\n    background: #ffffff;\n  }\n  .ub-table th {\n    background: #0f172a;\n    color: #ffffff;\n    padding: 14px 18px;\n    font-weight: 600;\n  }\n  .ub-table td {\n    padding: 14px 18px;\n    border-bottom: 1px solid #f1f5f9;\n    color: #334155;\n    vertical-align: top;\n  }\n  .ub-table tr:last-child td { border-bottom: none; }\n  .ub-table tr:nth-child(even) td { background: #f8fafc; }\n  .ub-highlight { font-weight: 700; color: #0f172a; }\n\n  \/* CONVERSION \/ CTA CARDS *\/\n  .ub-cta-card {\n    background: linear-gradient(135deg, #0a192f 0%, #0f2b48 100%);\n    color: #ffffff;\n    border-radius: 12px;\n    padding: 34px 36px;\n    margin: 3.5rem 0;\n    box-shadow: 0 10px 25px -5px rgba(10, 25, 47, 0.3);\n    text-align: center;\n  }\n  .ub-cta-title {\n    color: #ffffff;\n    font-size: 1.65rem;\n    font-weight: 800;\n    margin-bottom: 12px;\n  }\n  .ub-cta-desc {\n    color: #cbd5e1;\n    font-size: 1.05rem;\n    max-width: 750px;\n    margin: 0 auto 24px auto;\n    line-height: 1.6;\n  }\n  .ub-cta-actions {\n    display: flex;\n    justify-content: center;\n    gap: 16px;\n    flex-wrap: wrap;\n  }\n  .ub-btn-whatsapp {\n    background-color: #25d366;\n    color: #ffffff !important;\n    font-weight: 700;\n    font-size: 1.05rem;\n    padding: 14px 28px;\n    border-radius: 8px;\n    text-decoration: none;\n    display: inline-flex;\n    align-items: center;\n    gap: 10px;\n    transition: all 0.2s ease;\n  }\n  .ub-btn-whatsapp:hover {\n    background-color: #1ebc57;\n    transform: translateY(-2px);\n  }\n  .ub-btn-secondary {\n    background-color: rgba(255,255,255,0.1);\n    color: #ffffff !important;\n    border: 1px solid rgba(255,255,255,0.25);\n    font-weight: 600;\n    font-size: 1.05rem;\n    padding: 14px 26px;\n    border-radius: 8px;\n    text-decoration: none;\n    display: inline-flex;\n    align-items: center;\n    gap: 8px;\n    transition: all 0.2s ease;\n  }\n  .ub-btn-secondary:hover {\n    background-color: rgba(255,255,255,0.2);\n  }\n\n  \/* PROTOCOL STEPS *\/\n  .ub-protocol-steps {\n    list-style: none;\n    padding: 0;\n    counter-reset: step-counter;\n    margin: 2rem 0;\n  }\n  .ub-protocol-steps li {\n    position: relative;\n    padding-left: 58px;\n    margin-bottom: 1.8rem;\n  }\n  .ub-protocol-steps li::before {\n    content: counter(step-counter);\n    counter-increment: step-counter;\n    position: absolute;\n    left: 0;\n    top: 2px;\n    width: 42px;\n    height: 42px;\n    background: #0284c7;\n    color: #ffffff;\n    font-weight: 800;\n    border-radius: 50%;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    font-size: 1.1rem;\n    box-shadow: 0 2px 4px rgba(2, 132, 199, 0.3);\n  }\n  .ub-protocol-steps h4 {\n    margin: 0 0 6px 0;\n    font-size: 1.15rem;\n    color: #0f172a;\n  }\n\n  \/* FAQS *\/\n  .ub-faq-item {\n    border: 1px solid #e2e8f0;\n    border-radius: 8px;\n    padding: 20px 24px;\n    margin-bottom: 14px;\n    background: #ffffff;\n  }\n  .ub-faq-q {\n    font-weight: 700;\n    color: #0f172a;\n    font-size: 1.08rem;\n    margin-bottom: 8px;\n  }\n  .ub-faq-a {\n    color: #475569;\n    font-size: 0.95rem;\n    line-height: 1.75;\n    margin: 0;\n  }\n\n  \/* REFERENCES *\/\n  .ub-references {\n    background: #f8fafc;\n    border: 1px solid #e2e8f0;\n    border-radius: 8px;\n    padding: 24px 28px;\n    margin-top: 3.5rem;\n    font-size: 0.86rem;\n    color: #64748b;\n  }\n  .ub-references h4 {\n    color: #1e293b;\n    margin: 0 0 14px 0;\n    font-size: 0.95rem;\n    text-transform: uppercase;\n    letter-spacing: 0.05em;\n  }\n  .ub-references ol { margin: 0; padding-left: 20px; }\n  .ub-references li { margin-bottom: 10px; }\n  .ub-references strong { color: #334155; }\n\n  \/* LINKS *\/\n  .ub-internal-link {\n    color: #0284c7;\n    font-weight: 600;\n    text-decoration: underline;\n  }\n  .ub-internal-link:hover { color: #0369a1; }\n  .ub-external-link {\n    color: #475569;\n    text-decoration: underline;\n    font-size: 0.9em;\n  }\n\n  \/* ADDITIONS (CU drafts 2026-10-25) *\/\n  .ub-table caption { caption-side: top; text-align: left; font-weight: 700; color: #0f172a; padding: 12px 18px; font-size: 0.95rem; background: #f8fafc; }\n  .ub-table-note { font-size: 0.84rem; color: #64748b; margin: -1.6rem 0 2rem 0; }\n  .ub-quick-answer { font-size: 1.02rem; color: #14532d; margin: 0 0 6px 0; }\n  @media (max-width: 600px) {\n    .ub-clinical-post { font-size: 16px; }\n    .ub-clinical-post h2 { font-size: 1.45rem; }\n    .ub-toc-list { grid-template-columns: 1fr; }\n    .ub-cta-card { padding: 26px 18px; }\n    .ub-table th, .ub-table td { padding: 10px 12px; }\n  }\n\n  .ub-emergency { border:2px solid #dc2626; background:#fef2f2; border-radius:10px; padding:14px 18px; margin:0 0 1.6rem 0; color:#7f1d1d; }\n<\/style>\n\n<div class=\"ub-clinical-post\">\n\n  <!-- BYLINE. Yaln\u0131z yazar sat\u0131r\u0131; t\u0131bbi i\u00e7erik kontrol\u00fc sat\u0131r\u0131 YOK (rulebook \u00a71.2: REVIEW-LOG.csv'de tarihli sat\u0131r olmadan eklenmez). -->\n  <div class=\"ub-byline-card\">\n    <div>\n      <span class=\"ub-badge\">Koruyucu di\u015f hekimli\u011fi<\/span>\n      <span class=\"ub-badge ub-badge-gold\">Sistemik hastal\u0131klar<\/span>\n    <\/div>\n    <div style=\"margin-top: 12px; line-height: 1.7;\">\n      <strong>Yazar:<\/strong> <a href=\"https:\/\/ulubeydental.com\/tr\/dis-hekimlerimiz\/\" class=\"ub-internal-link\">Di\u015f Hekimi Ali Cem Ulubey<\/a> \u00b7 Ulubey Dental Clinic, Antalya<br>\n      <strong>Son g\u00fcncelleme:<\/strong> 26.10.2026<br>\n      <strong>\u0130\u00e7erik edit\u00f6r\u00fc:<\/strong> Dt. Ali Cem Ulubey \u00b7 <a href=\"mailto:info@ulubeydental.com\">info@ulubeydental.com<\/a>\n    <\/div>\n  <\/div>\n\n  <!-- AC\u0130L DURUM BLO\u011eU (rulebook \u00a73.3 TR, birebir; CTA yok) -->\n  <div class=\"ub-emergency\" role=\"note\">G\u00f6ze veya boyna yay\u0131lan \u015fi\u015flik, nefes alma\/yutma g\u00fc\u00e7l\u00fc\u011f\u00fc, y\u00fcksek ate\u015f veya durmayan kanama acil durumdur: 112&#8217;yi aray\u0131n.<\/div>\n  <p style=\"font-size:0.92rem;color:#64748b;\">Bu sayfa genel bilgilendirmedir; muayenenin yerini tutmaz.<\/p>\n\n  <!-- KISA CEVAP -->\n  <div class=\"ub-ai-summary-box\">\n    <div class=\"ub-ai-summary-header\">K\u0131sa cevap<\/div>\n    <p class=\"ub-quick-answer\">Genel sa\u011fl\u0131\u011f\u0131n\u0131z ile a\u011fz\u0131n\u0131z birbirini etkiler. Diyabet ile di\u015f eti hastal\u0131\u011f\u0131 aras\u0131nda iki y\u00f6nl\u00fc bir ili\u015fki vard\u0131r: diyabeti ve periodontitisi olanlar\u0131n HbA1c de\u011feri, di\u015f etleri sa\u011fl\u0131kl\u0131 olanlara g\u00f6re daha y\u00fcksektir; di\u015f eti hastal\u0131\u011f\u0131n\u0131n tedavisi HbA1c&#8217;yi 3 ay sonra %0,27\u20130,48 d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>. Kan suland\u0131r\u0131c\u0131lar di\u015f tedavisinde kanamay\u0131 kolayla\u015ft\u0131r\u0131r<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>, kemik g\u00fc\u00e7lendirici ila\u00e7lar nadir bir \u00e7ene kemi\u011fi nekrozu riski ta\u015f\u0131r<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup> ve bir\u00e7ok ila\u00e7 a\u011fz\u0131 kurutarak di\u015f \u00e7\u00fcr\u00fc\u011f\u00fc riskini art\u0131r\u0131r<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>. Di\u015f hekiminize her hastal\u0131\u011f\u0131n\u0131z\u0131 ve ilac\u0131n\u0131z\u0131 s\u00f6yleyin. Antalya Muratpa\u015fa&#8217;daki klini\u011fimizde bu durumlar s\u00f6z konusuysa cerrahiden \u00f6nce hekiminize dan\u0131\u015f\u0131r\u0131z.<\/p>\n    <div class=\"ub-ai-summary-grid\">\n      <div class=\"ub-ai-summary-item\"><strong>Diyabet ve di\u015f eti<\/strong><span>Di\u015f eti tedavisi HbA1c&#8217;yi 3 ay sonra %0,27\u20130,48 d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Kalp<\/strong><span>Di\u015f i\u015flemlerinden \u00f6nce antibiyotik korumas\u0131 yaln\u0131zca en y\u00fcksek riskli hastalara<sup><a href=\"#kaynak-2\">[2]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Kan suland\u0131r\u0131c\u0131lar<\/strong><span>Hekiminiz veya di\u015f hekiminiz s\u00f6ylemedik\u00e7e di\u015f tedavisi i\u00e7in de\u011fi\u015ftirmeyin<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>Kemik ila\u00e7lar\u0131<\/strong><span>MRONJ riski osteoporozda 1.000&#8217;de 1 ile 10.000&#8217;de 1 aras\u0131<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>; kanser tedavisinde genellikle 20&#8217;de 1&#8217;in alt\u0131nda<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>A\u011f\u0131z kurulu\u011fu<\/strong><span>\u0130la\u00e7lar ba\u015fl\u0131ca nedenlerdendir; a\u011f\u0131z kurulu\u011fu di\u015f \u00e7\u00fcr\u00fc\u011f\u00fcn\u00fc kolayla\u015ft\u0131r\u0131r<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>.<\/span><\/div>\n      <div class=\"ub-ai-summary-item\"><strong>A\u011f\u0131z yaralar\u0131<\/strong><span>3 haftadan uzun s\u00fcren bir yara i\u00e7in di\u015f hekimine veya hekime g\u00f6r\u00fcn\u00fcn<sup><a href=\"#kaynak-9\">[9]<\/a><\/sup>.<\/span><\/div>\n    <\/div>\n  <\/div>\n\n  <!-- \u0130\u00c7\u0130NDEK\u0130LER -->\n  <div class=\"ub-toc-box\">\n    <div class=\"ub-toc-title\">Bu rehberde<\/div>\n    <ul class=\"ub-toc-list\">\n      <li><a href=\"#neden-onemli\">1. Hastal\u0131klar\u0131n\u0131z di\u015f hekiminiz i\u00e7in neden \u00f6nemli?<\/a><\/li>\n      <li><a href=\"#diyabet-ve-dis-eti\">2. Diyabet ve di\u015f eti hastal\u0131\u011f\u0131: iki y\u00f6nl\u00fc bir ba\u011f<\/a><\/li>\n      <li><a href=\"#kalp-hastaligi\">3. Kalp hastal\u0131\u011f\u0131 ve di\u015f tedavisi<\/a><\/li>\n      <li><a href=\"#kan-sulandiricilar\">4. Kan suland\u0131r\u0131c\u0131lar ve di\u015f tedavisi<\/a><\/li>\n      <li><a href=\"#kemik-ilaclari\">5. Osteoporoz ve kanser ila\u00e7lar\u0131: bisfosfonat ve denosumab<\/a><\/li>\n      <li><a href=\"#agiz-kurulugu\">6. A\u011fz\u0131 kurutan ila\u00e7lar<\/a><\/li>\n      <li><a href=\"#hamilelik\">7. Hamilelik<\/a><\/li>\n      <li><a href=\"#tedavi-ve-yonlendirme\">8. Neyi tedavi ediyor, neyi y\u00f6nlendiriyoruz?<\/a><\/li>\n      <li><a href=\"#ne-zaman-dis-hekimine\">9. Ne zaman hemen di\u015f hekimine gitmeli?<\/a><\/li>\n      <li><a href=\"#sss\">10. S\u0131k sorulan sorular<\/a><\/li>\n      <li><a href=\"#kaynaklar\">11. Kaynaklar<\/a><\/li>\n    <\/ul>\n  <\/div>\n\n  <h2 id=\"neden-onemli\">Hastal\u0131klar\u0131n\u0131z di\u015f hekiminiz i\u00e7in neden \u00f6nemli?<\/h2>\n  <p>Bir\u00e7ok hastal\u0131k ve ila\u00e7 a\u011fz\u0131n nas\u0131l iyile\u015fti\u011fini, nas\u0131l kanad\u0131\u011f\u0131n\u0131 veya enfeksiyonla nas\u0131l m\u00fccadele etti\u011fini de\u011fi\u015ftirir; baz\u0131 di\u015f sorunlar\u0131 da genel sa\u011fl\u0131\u011f\u0131 etkiler. Di\u015f hekiminin tedaviyi planlamadan \u00f6nce t\u00fcm sa\u011fl\u0131k ge\u00e7mi\u015finizi sormas\u0131n\u0131n nedeni budur. Di\u015flerinizle ilgisiz g\u00f6r\u00fcnse bile, re\u00e7etesiz ve bitkisel \u00fcr\u00fcnler dahil<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup> her hastal\u0131\u011f\u0131n\u0131z\u0131 ve ilac\u0131n\u0131z\u0131 bize s\u00f6yleyin.<\/p>\n  <!-- IMAGE SLOT (designer, T-748 TR version): sistemik-hastaliklar-dis-hekimine-ne-soylemeli.svg \u00b7 alt=\"Be\u015f hastal\u0131k veya ila\u00e7, a\u011fza etkileri ve di\u015f hekiminize ne s\u00f6ylemeniz gerekti\u011fi\" \u00b7 caption: Temsili \u00e7izim, hasta g\u00f6r\u00fcnt\u00fcs\u00fc de\u011fildir. Diyabet, kalp hastal\u0131\u011f\u0131, kan suland\u0131r\u0131c\u0131lar, kemik ila\u00e7lar\u0131 ve a\u011fz\u0131 kurutan ila\u00e7lar: di\u015f hekiminize ne s\u00f6ylemelisiniz? Kaynaklar bu sayfada verilmi\u015ftir. \u00b7 note: G\u00d6RSEL YUVASI: EN oral-health-medical-conditions-what-to-tell-your-dentist.svg metinleri \u0130ngilizce \u2192 designer TR etiketli kopya \u00fcretir. \u00b7 enable after upload: <figure class=\"wp-block-image size-full ud-diagram\"><img src=\"SRC\" width=\"640\" height=\"767\" loading=\"lazy\" decoding=\"async\" alt=\"Be\u015f hastal\u0131k veya ila\u00e7, a\u011fza etkileri ve di\u015f hekiminize ne s\u00f6ylemeniz gerekti\u011fi\" style=\"width:100%;max-width:640px;height:auto\"><figcaption class=\"wp-element-caption\">Temsili \u00e7izim, hasta g\u00f6r\u00fcnt\u00fcs\u00fc de\u011fildir. Diyabet, kalp hastal\u0131\u011f\u0131, kan suland\u0131r\u0131c\u0131lar, kemik ila\u00e7lar\u0131 ve a\u011fz\u0131 kurutan ila\u00e7lar: di\u015f hekiminize ne s\u00f6ylemelisiniz? Kaynaklar bu sayfada verilmi\u015ftir.<\/figcaption><\/figure> -->\n  <div class=\"ub-table-wrapper\" id=\"sistemik-hastaliklar-tablosu\">\n    <table class=\"ub-table\">\n      <caption>Hastal\u0131klar ve ila\u00e7lar: a\u011fza etkisi ve di\u015f hekiminize s\u00f6ylemeniz gerekenler<\/caption>\n      <thead>\n        <tr><th scope=\"col\">Hastal\u0131k veya ila\u00e7<\/th><th scope=\"col\">A\u011fza etkisi<\/th><th scope=\"col\">Di\u015f hekiminize s\u00f6yleyin<\/th><\/tr>\n      <\/thead>\n      <tbody>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Diyabet<\/th><td>Periodontitisle iki y\u00f6nl\u00fc ba\u011f<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>; ge\u00e7meyen a\u011f\u0131z kurulu\u011fu<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup><\/td><td>Diyabet t\u00fcr\u00fc, ila\u00e7lar, son HbA1c de\u011feri<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Kalp hastal\u0131\u011f\u0131<\/th><td>Birka\u00e7 y\u00fcksek riskli durumda baz\u0131 i\u015flemlerden \u00f6nce antibiyotik korumas\u0131 gerekir<sup><a href=\"#kaynak-2\">[2]<\/a><\/sup><\/td><td>Tan\u0131, kapak veya ba\u015fka kalp ameliyat\u0131, ila\u00e7lar<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Kan suland\u0131r\u0131c\u0131lar<\/th><td>Daha kolay ve daha uzun s\u00fcre kanama<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup><\/td><td>Hangi ila\u00e7; varfarin kullan\u0131yorsan\u0131z INR kayd\u0131<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup><\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Bisfosfonat, denosumab<\/th><td>Nadir g\u00f6r\u00fclen ilaca ba\u011fl\u0131 \u00e7ene kemi\u011fi nekrozu (MRONJ)<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup><sup><a href=\"#kaynak-6\">[6]<\/a><\/sup><\/td><td>\u0130lac\u0131n ad\u0131, tablet mi i\u011fne mi, ne zamandan beri ve neden<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">A\u011fz\u0131 kurutan ila\u00e7lar; kanser tedavisi<\/th><td>A\u011f\u0131z kurulu\u011fu ve daha fazla di\u015f \u00e7\u00fcr\u00fc\u011f\u00fc<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup><\/td><td>Tam ila\u00e7 listesi; varsa radyoterapi veya kemoterapi<\/td><\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n  <p class=\"ub-table-note\">Kaynaklar h\u00fccrelerde belirtilmi\u015ftir. Bu tabloyu bu sayfaya ba\u011flant\u0131 vererek al\u0131nt\u0131layabilirsiniz.<\/p>\n\n  <h2 id=\"diyabet-ve-dis-eti\">Diyabet ve di\u015f eti hastal\u0131\u011f\u0131: iki y\u00f6nl\u00fc bir ba\u011f<\/h2>\n  <p>Diyabet ile periodontitis (ilerlemi\u015f di\u015f eti hastal\u0131\u011f\u0131) iki y\u00f6nde birbirine ba\u011fl\u0131d\u0131r. Uluslararas\u0131 Diyabet Federasyonu ile Avrupa Periodontoloji Federasyonu&#8217;nun ortak uzla\u015f\u0131 raporu; periodontitisi olanlarda kan \u015fekeri bozuklu\u011fu ve ins\u00fclin direnci riskinin artt\u0131\u011f\u0131na, diyabeti ve periodontitisi olanlar\u0131n HbA1c de\u011ferinin di\u015f etleri sa\u011fl\u0131kl\u0131 olanlara g\u00f6re belirgin olarak daha y\u00fcksek oldu\u011funa ve periodontitisin tip 2 diyabet geli\u015fme riskindeki art\u0131\u015fla ili\u015fkili oldu\u011funa dair g\u00fc\u00e7l\u00fc kan\u0131t bulmu\u015ftur<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>.<\/p>\n  <!-- IMAGE SLOT (designer, T-748 TR version): diyabet-dis-eti-iki-yonlu-bag.svg \u00b7 alt=\"Di\u015f eti hastal\u0131\u011f\u0131 ile diyabet aras\u0131ndaki iki y\u00f6nl\u00fc ba\u011f\u0131n \u015femas\u0131; di\u015f eti tedavisi HbA1c'yi 3. ayda %0,27\u20130,48 d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr\" \u00b7 caption: Temsili \u015fema. IDF\u2013EFP ortak uzla\u015f\u0131 raporuna dayan\u0131r. Di\u015f eti tedavisinin HbA1c \u00fczerindeki uzun vadeli etkisi kesin de\u011fildir. \u00b7 note: G\u00d6RSEL YUVASI: EN diabetes-gum-disease-two-way-link.svg metinleri \u0130ngilizce \u2192 designer TR etiketli kopya \u00fcretir. \u00b7 enable after upload: <figure class=\"wp-block-image size-full ud-diagram\"><img src=\"SRC\" width=\"640\" height=\"640\" loading=\"lazy\" decoding=\"async\" alt=\"Di\u015f eti hastal\u0131\u011f\u0131 ile diyabet aras\u0131ndaki iki y\u00f6nl\u00fc ba\u011f\u0131n \u015femas\u0131; di\u015f eti tedavisi HbA1c'yi 3. ayda %0,27\u20130,48 d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr\" style=\"width:100%;max-width:640px;height:auto\"><figcaption class=\"wp-element-caption\">Temsili \u015fema. IDF\u2013EFP ortak uzla\u015f\u0131 raporuna dayan\u0131r. Di\u015f eti tedavisinin HbA1c \u00fczerindeki uzun vadeli etkisi kesin de\u011fildir.<\/figcaption><\/figure> -->\n  <p>\u0130yi haber de ayn\u0131 y\u00f6ndedir: di\u015f eti tedavisi diyabetli ki\u015filerde g\u00fcvenli ve etkilidir ve 3 ay sonra HbA1c&#8217;de %0,27\u20130,48&#8217;lik d\u00fc\u015f\u00fc\u015fle ili\u015fkili bulunmu\u015ftur; ancak uzun vadeli veriler kesin de\u011fildir<sup><a href=\"#kaynak-1\">[1]<\/a><\/sup>. Ge\u00e7meyen a\u011f\u0131z kurulu\u011fu da diyabetle ili\u015fkili olabilir<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>.<\/p>\n  <ul>\n    <li><strong>Diyabetiniz varsa:<\/strong> di\u015f etlerinizi d\u00fczenli kontrol ettirin ve di\u015f hekiminize son HbA1c de\u011ferinizi s\u00f6yleyin.<\/li>\n    <li><strong>Di\u015f eti hastal\u0131\u011f\u0131n\u0131z varsa:<\/strong> tedavi a\u011fz\u0131n\u0131za iyi gelir ve kan \u015fekeri kontrol\u00fcne de yard\u0131mc\u0131 olabilir; bunu hekiminize de s\u00f6yleyin.<\/li>\n  <\/ul>\n  <p><strong>Klini\u011fimizde:<\/strong> bilinen bir hastal\u0131k olmasa bile her implant hastas\u0131ndan \u00f6nce di\u011fer rutin kan tahlilleriyle birlikte HbA1c&#8217;ye bakar\u0131z; bu tahliller \u00e7o\u011fu zaman hastan\u0131n bilmedi\u011fi y\u00fcksek bir HbA1c de\u011ferini ortaya \u00e7\u0131karm\u0131\u015ft\u0131r. Diyabetle implant yapt\u0131r\u0131p yapt\u0131ramayaca\u011f\u0131n\u0131z ve HbA1c s\u0131n\u0131rlar\u0131m\u0131z, <a href=\"https:\/\/ulubeydental.com\/tr\/kimler-implant-yaptirabilir\/\" class=\"ub-internal-link\">kimler implant yapt\u0131rabilir<\/a> rehberimizde anlat\u0131lmaktad\u0131r.<\/p>\n\n  <h2 id=\"kalp-hastaligi\">Kalp hastal\u0131\u011f\u0131 ve di\u015f tedavisi<\/h2>\n  <p>Kalp hastalar\u0131n\u0131n \u00e7o\u011fu i\u00e7in rutin di\u015f bak\u0131m\u0131 g\u00fcvenlidir ve iyi a\u011f\u0131z sa\u011fl\u0131\u011f\u0131 \u00f6nemlidir. Amerikan Kalp Derne\u011fi kan\u0131t\u0131 2021&#8217;de yeniden incelemi\u015f; di\u015f i\u015flemlerinden \u00f6nce koruyucu antibiyoti\u011fi yaln\u0131zca enfektif endokarditten k\u00f6t\u00fc sonu\u00e7 g\u00f6rme riski en y\u00fcksek hasta gruplar\u0131na \u00f6nermeye devam etmi\u015f, herkes i\u00e7in iyi a\u011f\u0131z sa\u011fl\u0131\u011f\u0131n\u0131n ve d\u00fczenli di\u015f bak\u0131m\u0131na eri\u015fimin kritik \u00f6nemini vurgulam\u0131\u015ft\u0131r<sup><a href=\"#kaynak-2\">[2]<\/a><\/sup>. Bu gruplardan birinde olup olmad\u0131\u011f\u0131n\u0131z\u0131 kardiyolo\u011funuz bilir.<\/p>\n  <p>Ya\u015fl\u0131 hastalarda implantlar\u0131 inceleyen bir derleme, kalp-damar hastal\u0131\u011f\u0131 olanlarda implant sa\u011fkal\u0131m\u0131n\u0131n sa\u011fl\u0131kl\u0131 hastalar\u0131nkine benzer veya daha y\u00fcksek olabilece\u011fini bulmu\u015ftur<sup><a href=\"#kaynak-8\">[8]<\/a><\/sup>. Bir\u00e7ok kalp hastas\u0131 kan suland\u0131r\u0131c\u0131 da kullan\u0131r; bu konu bir sonraki b\u00f6l\u00fcmdedir.<\/p>\n  <p><strong>Klini\u011fimizde:<\/strong> koruyucu antibiyotik almas\u0131 gereken hastalara i\u015flemden \u00f6nce antibiyotik verilir. Kapak de\u011fi\u015fimini, ge\u00e7irilmi\u015f endokarditi veya kalp ameliyat\u0131n\u0131 bize s\u00f6yleyin.<\/p>\n\n  <h2 id=\"kan-sulandiricilar\">Kan suland\u0131r\u0131c\u0131lar ve di\u015f tedavisi<\/h2>\n  <p>Kan suland\u0131r\u0131c\u0131 (antikoag\u00fclan) ve kan p\u0131ht\u0131la\u015fmas\u0131n\u0131 \u00f6nleyici (antiplatelet) ila\u00e7lar zararl\u0131 p\u0131ht\u0131lar\u0131 \u00f6nlemeye yard\u0131mc\u0131 olur; ancak \u00f6rne\u011fin bir \u00e7ekimden sonra daha kolay ve daha uzun s\u00fcre kanaman\u0131za da yol a\u00e7ar<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>. \u0130sko\u00e7ya Di\u015f Hekimli\u011fi Klinik Etkinlik Program\u0131 (SDCEP) hastalara \u015funlar\u0131 \u00f6nerir:<\/p>\n  <ul>\n    <li>hangi antikoag\u00fclan veya antiplatelet ilac\u0131 kulland\u0131\u011f\u0131n\u0131z\u0131 di\u015f hekiminize s\u00f6yleyin, varfarin kullan\u0131yorsan\u0131z INR kayd\u0131n\u0131z\u0131 g\u00f6sterin<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>;<\/li>\n    <li>di\u011fer t\u00fcm ila\u00e7lar\u0131n\u0131z\u0131 da s\u00f6yleyin, \u00e7\u00fcnk\u00fc aspirin ve ibuprofen, diklofenak gibi di\u011fer iltihap giderici a\u011fr\u0131 kesiciler kanamay\u0131 art\u0131rabilir<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>;<\/li>\n    <li>di\u015flerinizi her zamanki gibi temizlemeye devam edin, \u00e7\u00fcnk\u00fc sa\u011fl\u0131kl\u0131 di\u015f etleri daha az kanar<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>;<\/li>\n    <li>hekiminiz veya di\u015f hekiminiz s\u00f6ylemedik\u00e7e ilac\u0131n\u0131z\u0131 di\u015f tedavisi i\u00e7in de\u011fi\u015ftirmeyin<sup><a href=\"#kaynak-3\">[3]<\/a><\/sup>.<\/li>\n  <\/ul>\n  <p>SDCEP, tedavi sonras\u0131 a\u011fr\u0131 i\u00e7in antikoag\u00fclan veya antiplatelet ila\u00e7 kullanan hastalara, kullanabiliyorlarsa parasetamol\u00fc kutusunda yazd\u0131\u011f\u0131 \u015fekilde almalar\u0131n\u0131; aspirin, ibuprofen veya diklofenak gibi NSA\u0130\u0130&#8217;lerden ya da bunlar\u0131 i\u00e7eren ila\u00e7lardan ka\u00e7\u0131nmalar\u0131n\u0131; parasetamol uygun de\u011filse veya yetmiyorsa di\u015f hekimlerine dan\u0131\u015fmalar\u0131n\u0131 \u00f6nerir<sup><a href=\"#kaynak-4\">[4]<\/a><\/sup>. Genellikle re\u00e7ete etti\u011fimiz a\u011fr\u0131 kesiciler iltihap gidericidir; bu y\u00fczden cerrahiden \u00f6nce kan suland\u0131r\u0131c\u0131n\u0131z\u0131 bize s\u00f6yleyin, di\u015f hekimi a\u011fr\u0131 kesicinizi buna g\u00f6re se\u00e7er.<\/p>\n  <p>Tedaviden sonra kanama yeniden ba\u015flarsa, katlanm\u0131\u015f temiz ve nemli bir mendile veya gazl\u0131 beze 30 dakika bast\u0131r\u0131n ya da \u0131s\u0131r\u0131n; durmazsa di\u015f hekiminize ba\u015fvurun<sup><a href=\"#kaynak-4\">[4]<\/a><\/sup>.<\/p>\n  <p><strong>Klini\u011fimizde:<\/strong> ilac\u0131n ne i\u00e7in kullan\u0131ld\u0131\u011f\u0131 \u00f6nemlidir. Cerrahiden \u00f6nce ilac\u0131 yazan hekime dan\u0131\u015f\u0131r ve onun onay\u0131ndan sonra hareket ederiz; hekim i\u015fleme izin verir veya gerekirse ilac\u0131 ayarlar.<\/p>\n\n  <h2 id=\"kemik-ilaclari\">Osteoporoz ve kanser ila\u00e7lar\u0131: bisfosfonat ve denosumab<\/h2>\n  <p>Bisfosfonatlar ve denosumab, kemik erimesinde (osteoporoz) ve baz\u0131 kanserlerde kullan\u0131l\u0131r. \u00c7ene kemi\u011finin bir k\u0131sm\u0131n\u0131n a\u00e7\u0131\u011fa \u00e7\u0131kt\u0131\u011f\u0131, ilaca ba\u011fl\u0131 \u00e7ene kemi\u011fi nekrozu (MRONJ) adl\u0131 nadir bir yan etkiyle ili\u015fkilidirler<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>.<\/p>\n  <ul>\n    <li><strong>Osteoporoz:<\/strong> SDCEP riski 1.000&#8217;de 1 ile 10.000&#8217;de 1 aras\u0131nda verir. Risk s\u0131radan tedavilerin \u00e7o\u011funda \u00e7ok d\u00fc\u015f\u00fck ya da yok denecek kadar azd\u0131r; di\u015f \u00e7ekimi veya implant gibi kemi\u011fi etkileyen tedavilerde daha y\u00fcksektir, ancak yine de d\u00fc\u015f\u00fck kabul edilir<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>.<\/li>\n    <li><strong>Kanser:<\/strong> kanser i\u00e7in kullan\u0131lan kemik y\u0131k\u0131m\u0131n\u0131 \u00f6nleyici ila\u00e7larda risk genellikle 20&#8217;de 1&#8217;den azd\u0131r<sup><a href=\"#kaynak-6\">[6]<\/a><\/sup>.<\/li>\n    <li><strong>\u0130lac\u0131 kendi kendinize b\u0131rakmay\u0131n:<\/strong> t\u0131bbi yarar\u0131n\u0131n risklerinden \u00e7ok daha fazla olmas\u0131 muhtemeldir<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>.<\/li>\n    <li><strong>Hemen di\u015f hekimine ba\u015fvurun:<\/strong> \u00e7enede kar\u0131ncalanma, uyu\u015fma veya a\u011f\u0131rl\u0131k hissi, \u00e7ene a\u011fr\u0131s\u0131 ya da a\u011f\u0131zda k\u00f6t\u00fc tat, \u015fi\u015flik, iltihap, sallanan di\u015fler veya a\u00e7\u0131kta kemik fark ederseniz<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>.<\/li>\n  <\/ul>\n  <p><strong>Klini\u011fimizde:<\/strong> bisfosfonat kullanan hastalar\u0131 \u00f6nce kendi hekimlerine y\u00f6nlendiririz. Bisfosfonat i\u011fneyle (damardan) verildiyse 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yapmay\u0131z. D\u00fczenli kontroller ve iyi temizlik, cerrahiye hi\u00e7 ihtiya\u00e7 duyulmamas\u0131 olas\u0131l\u0131\u011f\u0131n\u0131 art\u0131r\u0131r<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>.<\/p>\n\n  <h2 id=\"agiz-kurulugu\">A\u011fz\u0131 kurutan ila\u00e7lar<\/h2>\n  <p>\u0130la\u00e7lar a\u011f\u0131z kurulu\u011funun ba\u015fl\u0131ca nedenlerindendir; NHS, a\u011f\u0131z kurulu\u011funun bir yan etki olup olmad\u0131\u011f\u0131n\u0131 g\u00f6rmek i\u00e7in ilac\u0131n\u0131z\u0131n kullanma talimat\u0131na bakman\u0131z\u0131 \u00f6nerir<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>. Di\u011fer nedenler aras\u0131nda susuz kalma, geceleri a\u011f\u0131zdan nefes alma, kayg\u0131, kanser tedavisi (radyoterapi veya kemoterapi) ve a\u011f\u0131z mantar\u0131 vard\u0131r; ge\u00e7meyen bir a\u011f\u0131z kurulu\u011funa diyabet veya Sj\u00f6gren sendromu gibi bir hastal\u0131k yol a\u00e7\u0131yor olabilir<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>.<\/p>\n  <p>T\u00fck\u00fcr\u00fck di\u015fleri korur; bu y\u00fczden a\u011fz\u0131n\u0131z kuruysa di\u015f \u00e7\u00fcr\u00fc\u011f\u00fc olas\u0131l\u0131\u011f\u0131 artar<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>. NHS&#8217;nin evde yap\u0131labilecek \u00f6nerileri<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>:<\/p>\n  <ul>\n    <li>g\u00fcn i\u00e7inde s\u0131k s\u0131k k\u00fc\u00e7\u00fck yudumlarla so\u011fuk su i\u00e7in ve yata\u011f\u0131n\u0131z\u0131n yan\u0131nda su bulundurun;<\/li>\n    <li>\u015fekersiz sak\u0131z \u00e7i\u011fneyin veya \u015fekersiz \u015feker emin;<\/li>\n    <li>g\u00fcnde iki kez f\u0131r\u00e7alay\u0131n ve alkols\u00fcz bir gargara kullan\u0131n;<\/li>\n    <li>alkol\u00fc, kafeini, gazl\u0131 i\u00e7ecekleri ve \u015fekerli veya asitli yiyecekleri azalt\u0131n, sigara i\u00e7meyin;<\/li>\n    <li>neden oldu\u011funu d\u00fc\u015f\u00fcnseniz bile, re\u00e7eteyle verilen bir ilac\u0131 hekiminize dan\u0131\u015fmadan b\u0131rakmay\u0131n.<\/li>\n  <\/ul>\n  <p>NHS, a\u011f\u0131z kurulu\u011fu konu\u015fmay\u0131 veya yemek yemeyi zorla\u015ft\u0131r\u0131yorsa, evde veya eczane \u00f6nerileriyle birka\u00e7 haftada d\u00fczelmiyorsa ya da re\u00e7eteli bir ilac\u0131n buna yol a\u00e7t\u0131\u011f\u0131n\u0131 d\u00fc\u015f\u00fcn\u00fcyorsan\u0131z bir hekime g\u00f6r\u00fcnmenizi \u00f6nerir<sup><a href=\"#kaynak-7\">[7]<\/a><\/sup>. Korunman\u0131n art\u0131r\u0131labilmesi i\u00e7in di\u015f hekiminize de s\u00f6yleyin.<\/p>\n\n  <h2 id=\"hamilelik\">Hamilelik<\/h2>\n  <p>Hamilelikte yaln\u0131zca hekiminizin onaylad\u0131\u011f\u0131 acil i\u015fleri, ikinci \u00fc\u00e7 ayl\u0131k d\u00f6nemde yapar\u0131z. \u00d6rne\u011fin kanal tedavisi gereken bir di\u015fin kanal\u0131 a\u00e7\u0131l\u0131r, ila\u00e7lan\u0131r ve ge\u00e7ici dolguyla kapat\u0131l\u0131r; kal\u0131c\u0131 tedavi do\u011fumdan sonraya ertelenir.<!-- LINK-AT-APPLY: hamilelikte di\u015f bak\u0131m\u0131 (N3-05 TR, master-v3 slug) yay\u0131na girince --><\/p>\n\n  <h2 id=\"tedavi-ve-yonlendirme\">Neyi tedavi ediyor, neyi y\u00f6nlendiriyoruz?<\/h2>\n  <p>\u0130yi bir di\u015f hekimi muayenehanesinin s\u0131n\u0131rlar\u0131n\u0131 bilir. Bu sayfadaki durumlar\u0131 ve ilgili sorunlar\u0131 \u015f\u00f6yle ele al\u0131yoruz:<\/p>\n  <div class=\"ub-table-wrapper\" id=\"tedavi-ve-yonlendirme-tablosu\">\n    <table class=\"ub-table\">\n      <caption>Ulubey Dental Clinic neyi tedavi eder, neyi y\u00f6nlendirir?<\/caption>\n      <thead>\n        <tr><th scope=\"col\">Durum<\/th><th scope=\"col\">Ne yap\u0131yoruz?<\/th><\/tr>\n      <\/thead>\n      <tbody>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Diyabetli hastalar dahil di\u015f eti hastal\u0131\u011f\u0131<\/th><td>Klinikte tedavi ederiz (bkz. <a href=\"https:\/\/ulubeydental.com\/tr\/dis-tasi-temizligi\/\" class=\"ub-internal-link\">di\u015f ta\u015f\u0131 temizli\u011fi<\/a>)<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Kan suland\u0131r\u0131c\u0131 kullanan ve cerrahi gereken hasta<\/th><td>\u0130lac\u0131 yazan hekime dan\u0131\u015f\u0131r, onun onay\u0131ndan sonra hareket ederiz<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Bisfosfonat tedavisi<\/th><td>Kendi hekiminize y\u00f6nlendirme; damardan bisfosfonattan sonra 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yok<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Koruyucu antibiyotik gerektiren kalp hastal\u0131\u011f\u0131<\/th><td>\u0130\u015flemden \u00f6nce koruyucu antibiyotik<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">A\u011f\u0131zda beyaz veya k\u0131rm\u0131z\u0131 lekeler<\/th><td>Bir \u00fcniversite di\u015f hekimli\u011fi fak\u00fcltesine y\u00f6nlendirme; klinikte biyopsi almay\u0131z<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Sinire yak\u0131n g\u00f6m\u00fcl\u00fc yirmilik di\u015f<\/th><td>3D tomografi (CBCT); y\u00fcksek riskli vakalar tercihen bir \u00fcniversite di\u015f hekimli\u011fi fak\u00fcltesine y\u00f6nlendirilir<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">\u00c7ene eklemi a\u011fr\u0131s\u0131 (TMD)<\/th><td>Klinikte haz\u0131rlanan gece pla\u011f\u0131 veya okl\u00fczal splint ve \u00e7ene egzersizlerinin anlat\u0131lmas\u0131; ileri vakalar fizyoterapiye y\u00f6nlendirilir<\/td><\/tr>\n        <tr><th scope=\"row\" class=\"ub-highlight\">Hamilelik<\/th><td>Yaln\u0131zca hekiminizin onay\u0131yla, ikinci \u00fc\u00e7 ayl\u0131k d\u00f6nemde acil i\u015fler<\/td><\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n  <p class=\"ub-table-note\">Ulubey Dental Clinic&#8217;in protokol\u00fc.<\/p>\n\n  <h2 id=\"ne-zaman-dis-hekimine\">Ne zaman hemen di\u015f hekimine gitmeli?<\/h2>\n  <div class=\"ub-callout-box alert\">\n    <div class=\"ub-callout-title\">\u015eunlar\u0131 fark ederseniz hemen di\u015f hekimine g\u00f6r\u00fcn\u00fcn<\/div>\n    <ul style=\"margin:0;\">\n      <li>3 haftadan uzun s\u00fcren, daha \u00f6nce ya\u015fad\u0131\u011f\u0131n\u0131z yaralardan farkl\u0131 g\u00f6r\u00fcnen veya kanayan bir a\u011f\u0131z yaras\u0131<sup><a href=\"#kaynak-9\">[9]<\/a><\/sup> ya da ge\u00e7meyen beyaz veya k\u0131rm\u0131z\u0131 bir leke;<\/li>\n      <li>kemik g\u00fc\u00e7lendirici ila\u00e7 kullan\u0131rken \u00e7enede a\u00e7\u0131kta kemik ya da kar\u0131ncalanma, uyu\u015fma veya a\u011f\u0131rl\u0131k hissi<sup><a href=\"#kaynak-5\">[5]<\/a><\/sup>;<\/li>\n      <li>di\u015f tedavisinden sonra 30 dakika bast\u0131rmayla durmayan kanama<sup><a href=\"#kaynak-4\">[4]<\/a><\/sup>;<\/li>\n      <li>\u00f6zellikle diyabetiniz varsa kanayan, \u015fi\u015fen veya \u00e7ekilen di\u015f etleri.<\/li>\n    <\/ul>\n  <\/div>\n  <p>G\u00f6ze veya boyna do\u011fru yay\u0131lan \u015fi\u015flik, nefes alma veya yutma g\u00fc\u00e7l\u00fc\u011f\u00fc, y\u00fcksek ate\u015f ya da durmayan kanama acil durumdur: 112&#8217;yi aray\u0131n. Bir hastal\u0131\u011f\u0131n veya ilac\u0131n planlanan di\u015f tedavisini nas\u0131l etkileyece\u011fine dair rutin bir soru randevunuzu bekleyebilir; ila\u00e7 listenizi yan\u0131n\u0131zda getirin.<\/p>\n\n  <h2 id=\"sss\">S\u0131k sorulan sorular<\/h2>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Diyabet di\u015fleri ve di\u015f etlerini etkiler mi?<\/h3>\n    <p class=\"ub-faq-a\">Evet. Diyabet ile periodontitis aras\u0131nda iki y\u00f6nl\u00fc bir ili\u015fki vard\u0131r: diyabeti ve di\u015f eti hastal\u0131\u011f\u0131 olanlar\u0131n HbA1c de\u011feri daha y\u00fcksek olma e\u011filimindedir; periodontitis de tip 2 diyabet riskindeki art\u0131\u015fla ili\u015fkilidir. Di\u015f eti hastal\u0131\u011f\u0131n\u0131n tedavisi diyabetli ki\u015filerde g\u00fcvenlidir ve 3 ay sonra HbA1c&#8217;yi %0,27\u20130,48 d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr. Ge\u00e7meyen a\u011f\u0131z kurulu\u011fu da diyabetle ili\u015fkili olabilir.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Kalp hastalar\u0131 di\u015f tedavisinden \u00f6nce antibiyotik almal\u0131 m\u0131?<\/h3>\n    <p class=\"ub-faq-a\">\u00c7o\u011funun almas\u0131 gerekmez. Amerikan Kalp Derne\u011fi, di\u015f i\u015flemlerinden \u00f6nce antibiyotik korumas\u0131n\u0131 yaln\u0131zca enfektif endokardit a\u00e7\u0131s\u0131ndan en y\u00fcksek risk ta\u015f\u0131yan hastalara \u00f6nerir ve herkes i\u00e7in iyi a\u011f\u0131z sa\u011fl\u0131\u011f\u0131n\u0131 vurgular. Bu grupta olup olmad\u0131\u011f\u0131n\u0131z\u0131 kardiyolo\u011funuz s\u00f6yleyebilir. Klini\u011fimizde koruyucu antibiyotik almas\u0131 gereken hastalara i\u015flemden \u00f6nce antibiyotik verilir.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Di\u015f hekimine gitmeden \u00f6nce kan suland\u0131r\u0131c\u0131m\u0131 b\u0131rakmal\u0131 m\u0131y\u0131m?<\/h3>\n    <p class=\"ub-faq-a\">Hay\u0131r, kendi kendinize b\u0131rakmay\u0131n. SDCEP, hekiminiz veya di\u015f hekiminiz s\u00f6ylemedik\u00e7e antikoag\u00fclan veya antiplatelet ilac\u0131n\u0131z\u0131 di\u015f tedavisi i\u00e7in de\u011fi\u015ftirmemenizi \u00f6nerir. Hangi ilac\u0131 kulland\u0131\u011f\u0131n\u0131z\u0131 di\u015f hekiminize s\u00f6yleyin. Cerrahiden \u00f6nce ilac\u0131 yazan hekime dan\u0131\u015f\u0131r ve onun onay\u0131ndan sonra hareket ederiz.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Osteoporoz i\u00e7in bisfosfonat kullan\u0131yorsam di\u015f tedavisi g\u00fcvenli mi?<\/h3>\n    <p class=\"ub-faq-a\">S\u0131radan di\u015f tedavilerinin \u00e7o\u011funun riski \u00e7ok d\u00fc\u015f\u00fckt\u00fcr. Nadir g\u00f6r\u00fclen \u00e7ene yan etkisi MRONJ&#8217;un riski osteoporoz tedavisinde 1.000&#8217;de 1 ile 10.000&#8217;de 1 aras\u0131ndad\u0131r; di\u015f \u00e7ekimi veya implanttan sonra daha y\u00fcksektir, ancak yine de d\u00fc\u015f\u00fckt\u00fcr. \u0130lac\u0131n\u0131za devam edin. Bisfosfonat kullanan hastalar\u0131 \u00f6nce hekimlerine y\u00f6nlendiririz; damardan bisfosfonattan sonra 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yapmay\u0131z.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Hangi ila\u00e7lar a\u011f\u0131z kurulu\u011fu yapar?<\/h3>\n    <p class=\"ub-faq-a\">Bir\u00e7ok ila\u00e7 a\u011f\u0131z kurulu\u011funu yan etki olarak sayar; bu y\u00fczden kendi ilac\u0131n\u0131z\u0131n kullanma talimat\u0131na bak\u0131n. Kanser tedavisi, susuz kalma, a\u011f\u0131zdan nefes alma, kayg\u0131, diyabet ve Sj\u00f6gren sendromu da a\u011f\u0131z kurulu\u011funa yol a\u00e7abilir. A\u011f\u0131z kurulu\u011fu di\u015f \u00e7\u00fcr\u00fc\u011f\u00fcn\u00fc kolayla\u015ft\u0131r\u0131r. Re\u00e7eteyle verilen bir ilac\u0131 hekiminize dan\u0131\u015fmadan b\u0131rakmay\u0131n; s\u0131k s\u0131k su i\u00e7in, \u015fekersiz sak\u0131z kullan\u0131n ve di\u015f hekiminize s\u00f6yleyin.<\/p>\n  <\/div>\n  <div class=\"ub-faq-item\">\n    <h3 class=\"ub-faq-q\">Klinik, a\u011f\u0131zdaki beyaz veya k\u0131rm\u0131z\u0131 lekeler gibi lezyonlar\u0131 tedavi ediyor mu?<\/h3>\n    <p class=\"ub-faq-a\">Her ziyarette a\u011fz\u0131 muayene ederiz, ancak klinikte biyopsi almay\u0131z. \u0130ncelenmesi gereken beyaz veya k\u0131rm\u0131z\u0131 lekeleri bir \u00fcniversite di\u015f hekimli\u011fi fak\u00fcltesine y\u00f6nlendiririz. NHS, 3 haftadan uzun s\u00fcren bir a\u011f\u0131z yaras\u0131 i\u00e7in bir di\u015f hekimine veya hekime g\u00f6r\u00fcnmeyi \u00f6nerir.<\/p>\n  <\/div>\n\n  <!-- CTA: acil olmayan randevu; acil durum blo\u011fundan ayr\u0131 (rulebook \u00a73.3). -->\n  <div class=\"ub-cta-card\">\n    <div class=\"ub-cta-title\">Acil olmayan randevu<\/div>\n    <div class=\"ub-cta-desc\">Bir hastal\u0131\u011f\u0131n\u0131z varsa ve di\u015f tedavisine ihtiyac\u0131n\u0131z varsa ila\u00e7 listenizi ve r\u00f6ntgeninizi WhatsApp&#8217;tan g\u00f6nderebilir ya da Pazartesi\u2013Cumartesi 09:00\u201319:00 aras\u0131nda klini\u011fimize gelebilirsiniz. Mesajlar genellikle 4 saat i\u00e7inde yan\u0131tlan\u0131r. A\u011fr\u0131 veya \u015fi\u015flik i\u00e7in <a href=\"https:\/\/ulubeydental.com\/tr\/antalya-acil-dis-hekimi\/\" class=\"ub-internal-link\">Antalya&#8217;da acil di\u015f hekimi<\/a> sayfam\u0131za bak\u0131n. Kesin tan\u0131 ve tedavi plan\u0131 muayene ve r\u00f6ntgen sonras\u0131nda netle\u015fir.<br><small>\u00c7a\u011flayan Mh., Bar\u0131naklar Blv., \u00d6zen 2 Apt. No: 109A, Muratpa\u015fa\/Antalya (Lara b\u00f6lgesi) \u00b7 Otopark imk\u00e2n\u0131 mevcuttur. \u00b7 Pazartesi\u2013Cumartesi 09:00\u201319:00<\/small><\/div>\n    <div class=\"ub-cta-actions\">\n      <a href=\"https:\/\/wa.me\/905403240004?text=Merhaba%2C%20bir%20hastal%C4%B1%C4%9F%C4%B1m%20var%20ve%20di%C5%9F%20tedavisiyle%20ilgili%20bir%20sorum%20var.\" class=\"ub-btn-whatsapp\" target=\"_blank\" rel=\"noopener noreferrer\">WhatsApp&#8217;tan yaz\u0131n (+90 540 324 00 04)<\/a>\n      <a href=\"https:\/\/ulubeydental.com\/tr\/genel-dis-hekimligi\/\" class=\"ub-btn-secondary\">Genel di\u015f hekimli\u011fi<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"ub-references\" id=\"kaynaklar\">\n    <h4>Kaynaklar (\u0130ngilizce)<\/h4>\n    <ol>\n      <li id=\"kaynak-1\"><strong>Sanz M, Ceriello A, Buysschaert M, et al.<\/strong> Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. <em>J Clin Periodontol<\/em>. 2018;45(2):138-149. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29280174\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/29280174<\/a><\/li>\n      <li id=\"kaynak-2\"><strong>Wilson WR, Gewitz M, Lockhart PB, et al.<\/strong> Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. <em>Circulation<\/em>. 2021;143(20):e963-e978. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33853363\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/33853363<\/a><\/li>\n      <li id=\"kaynak-3\"><strong>SDCEP.<\/strong> Anticoagulant or antiplatelet medication and your dental treatment: information for patients (2022; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.sdcep.org.uk\/media\/r3cjkyl5\/sdcep-anticoagulant-or-antiplatelet-medication-and-your-dental-treatment.pdf\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.sdcep.org.uk\/media\/r3cjkyl5\/sdcep-anticoagulant-or-antiplatelet-medication-and-your-dental-treatment.pdf<\/a><\/li>\n      <li id=\"kaynak-4\"><strong>SDCEP.<\/strong> Post-treatment advice for dental patients taking anticoagulant or antiplatelet medication (Mart 2022; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.sdcep.org.uk\/media\/bocnpjel\/sdcep-post-treatment-advice-for-dental-patients.pdf\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.sdcep.org.uk\/media\/bocnpjel\/sdcep-post-treatment-advice-for-dental-patients.pdf<\/a><\/li>\n      <li id=\"kaynak-5\"><strong>SDCEP.<\/strong> Dental advice for patients prescribed anti-resorptive drugs for the treatment of osteoporosis or other non-malignant diseases of bone (hasta bro\u015f\u00fcr\u00fc; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.sdcep.org.uk\/media\/0fldawef\/sdcep-mronj-information-for-osteoporosis-patients.pdf\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.sdcep.org.uk\/media\/0fldawef\/sdcep-mronj-information-for-osteoporosis-patients.pdf<\/a><\/li>\n      <li id=\"kaynak-6\"><strong>SDCEP.<\/strong> MRONJ information for patients prescribed anti-resorptive or anti-angiogenic drugs for cancer (hasta bro\u015f\u00fcr\u00fc; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.sdcep.org.uk\/media\/bdwo1l44\/sdcep-mronj-information-for-cancer-patients.pdf\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.sdcep.org.uk\/media\/bdwo1l44\/sdcep-mronj-information-for-cancer-patients.pdf<\/a><\/li>\n      <li id=\"kaynak-7\"><strong>NHS.<\/strong> Dry mouth (son inceleme 29 Kas\u0131m 2023; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.nhs.uk\/conditions\/dry-mouth\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.nhs.uk\/conditions\/dry-mouth<\/a><\/li>\n      <li id=\"kaynak-8\"><strong>Schimmel M, Srinivasan M, McKenna G, M\u00fcller F.<\/strong> Effect of advanced age and\/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis. <em>Clin Oral Implants Res<\/em>. 2018;29 Suppl 16:311-330. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30328186\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">pubmed.ncbi.nlm.nih.gov\/30328186<\/a><\/li>\n      <li id=\"kaynak-9\"><strong>NHS.<\/strong> Mouth ulcers (son inceleme 11 Mart 2024; eri\u015fim 25 Ekim 2026). <a href=\"https:\/\/www.nhs.uk\/conditions\/mouth-ulcers\/\" class=\"ub-external-link\" target=\"_blank\" rel=\"noopener\">www.nhs.uk\/conditions\/mouth-ulcers<\/a><\/li>\n    <\/ol>\n    <p style=\"margin:12px 0 0 0;\">Bu yaz\u0131 genel hasta bilgilendirmesidir; klinik muayenenin yerini tutmaz. Her cerrahi veya giri\u015fimsel i\u015flemde sonu\u00e7lar ki\u015fiden ki\u015fiye de\u011fi\u015fiklik g\u00f6sterebilir. \u0130\u015flem \u00f6ncesinde hekiminizden detayl\u0131 g\u00f6r\u00fc\u015f alman\u0131z \u00f6nerilir.<\/p>\n  <\/div>\n\n<\/div>\n\n<script type=\"application\/ld+json\">\n{\n \"@context\": \"https:\/\/schema.org\",\n \"@graph\": [\n  {\n   \"@type\": \"MedicalWebPage\",\n   \"@id\": \"https:\/\/ulubeydental.com\/tr\/sistemik-hastaliklar-ve-agiz-sagligi\/#webpage\",\n   \"url\": \"https:\/\/ulubeydental.com\/tr\/sistemik-hastaliklar-ve-agiz-sagligi\/\",\n   \"name\": \"Sistemik Hastal\u0131klar ve A\u011f\u0131z Sa\u011fl\u0131\u011f\u0131: Diyabet, Kalp, Kan Suland\u0131r\u0131c\u0131\",\n   \"headline\": \"Sistemik Hastal\u0131klar ve A\u011f\u0131z Sa\u011fl\u0131\u011f\u0131: Diyabet, Kalp, Kan Suland\u0131r\u0131c\u0131\",\n   \"description\": \"Diyabet di\u015f etini nas\u0131l etkiler? Kan suland\u0131r\u0131c\u0131, bisfosfonat ve a\u011f\u0131z kurulu\u011fu yapan ila\u00e7larla di\u015f tedavisi. Di\u015f hekiminize ne s\u00f6ylemelisiniz? Antalya Muratpa\u015fa'dan.\",\n   \"inLanguage\": \"tr\",\n   \"isPartOf\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/#website\"\n   },\n   \"author\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/#dr-ali-cem-ulubey\"\n   },\n   \"publisher\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/#organization\"\n   },\n   \"datePublished\": \"2026-10-26\",\n   \"dateModified\": \"2026-10-26\",\n   \"medicalAudience\": {\n    \"@type\": \"MedicalAudience\",\n    \"audienceType\": \"Patient\"\n   },\n   \"about\": [\n    {\n     \"@type\": \"MedicalCondition\",\n     \"name\": \"Periodontitis\",\n     \"associatedAnatomy\": {\n      \"@type\": \"AnatomicalStructure\",\n      \"name\": \"Di\u015f eti\"\n     }\n    },\n    {\n     \"@type\": \"MedicalCondition\",\n     \"name\": \"Diyabet\"\n    },\n    {\n     \"@type\": \"MedicalCondition\",\n     \"name\": \"\u0130laca ba\u011fl\u0131 \u00e7ene kemi\u011fi nekrozu\",\n     \"alternateName\": \"MRONJ\"\n    },\n    {\n     \"@type\": \"MedicalCondition\",\n     \"name\": \"Kserostomi\",\n     \"alternateName\": \"A\u011f\u0131z kurulu\u011fu\"\n    },\n    {\n     \"@type\": \"MedicalCondition\",\n     \"name\": \"Kalp-damar hastal\u0131\u011f\u0131\"\n    }\n   ],\n   \"citation\": [\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/29280174\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/33853363\/\",\n    \"https:\/\/www.sdcep.org.uk\/media\/r3cjkyl5\/sdcep-anticoagulant-or-antiplatelet-medication-and-your-dental-treatment.pdf\",\n    \"https:\/\/www.sdcep.org.uk\/media\/bocnpjel\/sdcep-post-treatment-advice-for-dental-patients.pdf\",\n    \"https:\/\/www.sdcep.org.uk\/media\/0fldawef\/sdcep-mronj-information-for-osteoporosis-patients.pdf\",\n    \"https:\/\/www.sdcep.org.uk\/media\/bdwo1l44\/sdcep-mronj-information-for-cancer-patients.pdf\",\n    \"https:\/\/www.nhs.uk\/conditions\/dry-mouth\/\",\n    \"https:\/\/pubmed.ncbi.nlm.nih.gov\/30328186\/\",\n    \"https:\/\/www.nhs.uk\/conditions\/mouth-ulcers\/\"\n   ]\n  },\n  {\n   \"@type\": \"FAQPage\",\n   \"@id\": \"https:\/\/ulubeydental.com\/tr\/sistemik-hastaliklar-ve-agiz-sagligi\/#sss\",\n   \"isPartOf\": {\n    \"@id\": \"https:\/\/ulubeydental.com\/tr\/sistemik-hastaliklar-ve-agiz-sagligi\/#webpage\"\n   },\n   \"mainEntity\": [\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Diyabet di\u015fleri ve di\u015f etlerini etkiler mi?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Evet. Diyabet ile periodontitis aras\u0131nda iki y\u00f6nl\u00fc bir ili\u015fki vard\u0131r: diyabeti ve di\u015f eti hastal\u0131\u011f\u0131 olanlar\u0131n HbA1c de\u011feri daha y\u00fcksek olma e\u011filimindedir; periodontitis de tip 2 diyabet riskindeki art\u0131\u015fla ili\u015fkilidir. Di\u015f eti hastal\u0131\u011f\u0131n\u0131n tedavisi diyabetli ki\u015filerde g\u00fcvenlidir ve 3 ay sonra HbA1c'yi %0,27\u20130,48 d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr. Ge\u00e7meyen a\u011f\u0131z kurulu\u011fu da diyabetle ili\u015fkili olabilir.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Kalp hastalar\u0131 di\u015f tedavisinden \u00f6nce antibiyotik almal\u0131 m\u0131?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"\u00c7o\u011funun almas\u0131 gerekmez. Amerikan Kalp Derne\u011fi, di\u015f i\u015flemlerinden \u00f6nce antibiyotik korumas\u0131n\u0131 yaln\u0131zca enfektif endokardit a\u00e7\u0131s\u0131ndan en y\u00fcksek risk ta\u015f\u0131yan hastalara \u00f6nerir ve herkes i\u00e7in iyi a\u011f\u0131z sa\u011fl\u0131\u011f\u0131n\u0131 vurgular. Bu grupta olup olmad\u0131\u011f\u0131n\u0131z\u0131 kardiyolo\u011funuz s\u00f6yleyebilir. Klini\u011fimizde koruyucu antibiyotik almas\u0131 gereken hastalara i\u015flemden \u00f6nce antibiyotik verilir.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Di\u015f hekimine gitmeden \u00f6nce kan suland\u0131r\u0131c\u0131m\u0131 b\u0131rakmal\u0131 m\u0131y\u0131m?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Hay\u0131r, kendi kendinize b\u0131rakmay\u0131n. SDCEP, hekiminiz veya di\u015f hekiminiz s\u00f6ylemedik\u00e7e antikoag\u00fclan veya antiplatelet ilac\u0131n\u0131z\u0131 di\u015f tedavisi i\u00e7in de\u011fi\u015ftirmemenizi \u00f6nerir. Hangi ilac\u0131 kulland\u0131\u011f\u0131n\u0131z\u0131 di\u015f hekiminize s\u00f6yleyin. Cerrahiden \u00f6nce ilac\u0131 yazan hekime dan\u0131\u015f\u0131r ve onun onay\u0131ndan sonra hareket ederiz.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Osteoporoz i\u00e7in bisfosfonat kullan\u0131yorsam di\u015f tedavisi g\u00fcvenli mi?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"S\u0131radan di\u015f tedavilerinin \u00e7o\u011funun riski \u00e7ok d\u00fc\u015f\u00fckt\u00fcr. Nadir g\u00f6r\u00fclen \u00e7ene yan etkisi MRONJ'un riski osteoporoz tedavisinde 1.000'de 1 ile 10.000'de 1 aras\u0131ndad\u0131r; di\u015f \u00e7ekimi veya implanttan sonra daha y\u00fcksektir, ancak yine de d\u00fc\u015f\u00fckt\u00fcr. \u0130lac\u0131n\u0131za devam edin. Bisfosfonat kullanan hastalar\u0131 \u00f6nce hekimlerine y\u00f6nlendiririz; damardan bisfosfonattan sonra 5 y\u0131la kadar a\u011f\u0131z i\u00e7i cerrahi yapmay\u0131z.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Hangi ila\u00e7lar a\u011f\u0131z kurulu\u011fu yapar?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Bir\u00e7ok ila\u00e7 a\u011f\u0131z kurulu\u011funu yan etki olarak sayar; bu y\u00fczden kendi ilac\u0131n\u0131z\u0131n kullanma talimat\u0131na bak\u0131n. Kanser tedavisi, susuz kalma, a\u011f\u0131zdan nefes alma, kayg\u0131, diyabet ve Sj\u00f6gren sendromu da a\u011f\u0131z kurulu\u011funa yol a\u00e7abilir. A\u011f\u0131z kurulu\u011fu di\u015f \u00e7\u00fcr\u00fc\u011f\u00fcn\u00fc kolayla\u015ft\u0131r\u0131r. Re\u00e7eteyle verilen bir ilac\u0131 hekiminize dan\u0131\u015fmadan b\u0131rakmay\u0131n; s\u0131k s\u0131k su i\u00e7in, \u015fekersiz sak\u0131z kullan\u0131n ve di\u015f hekiminize s\u00f6yleyin.\"\n     }\n    },\n    {\n     \"@type\": \"Question\",\n     \"name\": \"Klinik, a\u011f\u0131zdaki beyaz veya k\u0131rm\u0131z\u0131 lekeler gibi lezyonlar\u0131 tedavi ediyor mu?\",\n     \"acceptedAnswer\": {\n      \"@type\": \"Answer\",\n      \"text\": \"Her ziyarette a\u011fz\u0131 muayene ederiz, ancak klinikte biyopsi almay\u0131z. \u0130ncelenmesi gereken beyaz veya k\u0131rm\u0131z\u0131 lekeleri bir \u00fcniversite di\u015f hekimli\u011fi fak\u00fcltesine y\u00f6nlendiririz. NHS, 3 haftadan uzun s\u00fcren bir a\u011f\u0131z yaras\u0131 i\u00e7in bir di\u015f hekimine veya hekime g\u00f6r\u00fcnmeyi \u00f6nerir.\"\n     }\n    }\n   ]\n  }\n ]\n}\n<\/script>\n\n","protected":false},"excerpt":{"rendered":"<p>Koruyucu di\u015f hekimli\u011fi Sistemik hastal\u0131klar Yazar: Di\u015f Hekimi Ali Cem Ulubey \u00b7 Ulubey Dental Clinic, Antalya Son g\u00fcncelleme: 26.10.2026 \u0130\u00e7erik edit\u00f6r\u00fc: Dt. Ali Cem Ulubey \u00b7 info@ulubeydental.com G\u00f6ze veya boyna yay\u0131lan \u015fi\u015flik, nefes alma\/yutma g\u00fc\u00e7l\u00fc\u011f\u00fc, y\u00fcksek ate\u015f veya durmayan kanama acil durumdur: 112&#8217;yi aray\u0131n. Bu sayfa genel bilgilendirmedir; muayenenin yerini tutmaz. K\u0131sa cevap Genel sa\u011fl\u0131\u011f\u0131n\u0131z&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_joinchat":[],"footnotes":""},"categories":[315],"tags":[],"class_list":["post-9052","post","type-post","status-publish","format-standard","hentry","category-hasta-rehberi"],"taxonomy_info":{"category":[{"value":315,"label":"Hasta Rehberi"}]},"featured_image_src_large":false,"author_info":{"display_name":"Dt. Ali Cem Ulubey","author_link":"https:\/\/ulubeydental.com\/tr\/author\/ali-cem\/"},"comment_info":0,"category_info":[{"term_id":315,"name":"Hasta Rehberi","slug":"hasta-rehberi","term_group":0,"term_taxonomy_id":315,"taxonomy":"category","description":"","parent":0,"count":30,"filter":"raw","cat_ID":315,"category_count":30,"category_description":"","cat_name":"Hasta Rehberi","category_nicename":"hasta-rehberi","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/posts\/9052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/comments?post=9052"}],"version-history":[{"count":0,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/posts\/9052\/revisions"}],"wp:attachment":[{"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/media?parent=9052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/categories?post=9052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ulubeydental.com\/tr\/wp-json\/wp\/v2\/tags?post=9052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}